BioCardia (BCDA) Set to Announce Quarterly Earnings on Wednesday

BioCardia (NASDAQ:BCDA) is set to post its quarterly earnings results after the market closes on Wednesday, November 13th. Analysts expect BioCardia to post earnings of ($1.19) per share for the quarter.

BioCardia (NASDAQ:BCDA) last announced its earnings results on Tuesday, August 13th. The company reported ($0.88) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.78). On average, analysts expect BioCardia to post $-5 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

BioCardia Stock Performance

BioCardia stock opened at $2.46 on Thursday. The stock has a market cap of $5.23 million, a PE ratio of -0.45 and a beta of 1.28. The stock has a 50-day moving average of $2.68 and a two-hundred day moving average of $3.48. BioCardia has a one year low of $1.96 and a one year high of $23.25.

Analysts Set New Price Targets

Separately, HC Wainwright reiterated a “buy” rating and issued a $25.00 target price on shares of BioCardia in a research note on Monday, October 28th.

BioCardia Company Profile

BioCardia, Inc, a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. Its lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia.